Thorsten Rudroff

June 23, 2022

Differences in Inhibitory Control and Resting Brain Metabolism between Older Chronic Users of Tetrahydrocannabinol (THC) or Cannabidiol (CBD)—A Pilot Study

Abstract Δ9-Tetrahydrocannabinol is the main psychoactive component of cannabis and cannabidiol is purportedly responsible for many of the medicinal benefits.…

December 23, 2021

Disparity between Perceptual Fall Risk and Physiological Fall Risk in Older Cannabis Users: A Pilot Study

Abstract Aging is associated with cognitive decline and increased fall risk. Cognitive impairment is associated with cannabis use, which is…

January 21, 2021

Increased Likelihood of Falling in Older Cannabis Users vs. Non-Users

Abstract Cannabis is one of the most common drugs in the United States and is the third most prevalent substance…

October 13, 2018

Multiple Sclerosis, Cannabis Use, and Clinical Disability: A Preliminary [18F]-Fluorodeoxyglucose Positron Emission Tomography Study

Abstract Introduction: Long-term consequences of medicinal cannabis use in people with multiple sclerosis (PwMS) are unknown. This study investigated whether…